Our Mission
We make precision medicine technology simple and affordable at point of care, powered by comprehensive clinical decision support technology services and tools for providers. MiGenesys™ pharmacogenetic tests give insights to physicians on how a patient's DNA affects their response to drugs and assist the physician with personalizing the drug selection and dose adjustment to improve medication therapy safety and efficacy.
Simple
Our reports are simple and easy to understand. They provide actionable clinical guidance for physicians who can now use precision medicine in their day to day practice.
Affordable
We strive to increase access to precision medicine by making it affordable for all.
PGx Test
MiGenesys Pharmacogenetic (PGx) test analyzes a patient’s DNA to determine how he or she may respond to certain medications. This information can help providers make better prescription decisions, protect patients from adverse drug reactions and drug ineffectiveness, and reduce healthcare costs.
Pgx Panels
MiGenesys PGx
Cardiovascular
MiGenesys™ cardiovascular test provides pharmacogenetic insights in to routinely prescribed drug classes used in cardiology, including anti-platelet, anti-coagulant, statins, beta-blockers, ACE inhibitors, calcium channel blockers and hormone therapies.
MiGenesys PGx
Neurology
MiGenesys™ Neurology test provides pharmacogenetic insights in to routinely prescribed drug classes used in Neurology.
MiGenesys PGx
General Practice
MiGenesys™ General practice test provides pharmacogenetic insights in to commonly prescribed medicines by general practitioners.
MiGenesys PGx
Pain
MiGenesys™ Pain test provides pharmacogenetic insights in to opioids, non-steroidal anti-inflammatory drugs, and other pain drugs.
MiGenesys PGx
Gastroenterology
MiGenesys™ Gastroenterology test provides pharmacogenetic insights in to acid reducers including proton pump inhibitors.
MiGenesys PGx
Psychiatry
MiGenesys™ Psychiatry test provides pharmacogenetic insights in to routinely prescribed drug classes used in psychiatry including selective serotonin reuptake inhibitors, or SSRI, serotonin-norepinephrine reuptake inhibitors, or SNRI, and tricyclic antidepressants as well as antipsychotic drugs.
Our Partners
MiGenesys is partnering with premier hospitals, clinics, labs, and healthcare organizations around the world who are committed to bringing latest advances in healthcare technology into patient care and provide personalized treatment options for patients.
Colombia
Panama
Mexico
Costa Rica
![Logo Clínica Zahha[2].PNG](https://static.wixstatic.com/media/0cb46d_b27ec682c5524c6f80b82b999a6ed293~mv2.png/v1/fill/w_148,h_67,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/Logo%20Cl%C3%ADnica%20Zahha%5B2%5D_PNG.png)
UK
